These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11354536)

  • 1. Biology of renal cell carcinoma: changing concepts in classification and staging.
    Pantuck AJ; Zisman A; Belldegrun A
    Semin Urol Oncol; 2001 May; 19(2):72-9. PubMed ID: 11354536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy.
    Lam JS; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6304S-9S. PubMed ID: 15448022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and selection for clinical studies of patients with kidney cancer.
    Lam JS; Klatte T; Kim HL; Patard JJ; Breda A; Zisman A; Pantuck AJ; Figlin RA
    Crit Rev Oncol Hematol; 2008 Mar; 65(3):235-62. PubMed ID: 17931881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection.
    Breda A; Konijeti R; Lam JS
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):847-62. PubMed ID: 17555395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and prognosis of renal cell carcinoma: highlights from an international consensus workshop.
    Bostwick DG; Murphy GP
    Semin Urol Oncol; 1998 Feb; 16(1):46-52. PubMed ID: 9508083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of gene expression analysis of renal cell carcinoma.
    Leppert JT; Pantuck AJ
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):293-9. PubMed ID: 16445381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma.
    Lohse CM; Cheville JC
    Clin Lab Med; 2005 Jun; 25(2):433-64. PubMed ID: 15848745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma.
    Lam JS; Breda A; Belldegrun AS; Figlin RA
    J Clin Oncol; 2006 Dec; 24(35):5565-75. PubMed ID: 17158542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors in renal cell carcinoma].
    Letang N; Cabaniols L; Pouessel D; Robert M; Iborra F; Culine S; Patard JJ; Guiter J; Thuret R
    Bull Cancer; 2009 Apr; 96(4):475-84. PubMed ID: 19357021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype.
    Delahunt B; Bethwaite PB; Nacey JN
    Pathology; 2007 Oct; 39(5):459-65. PubMed ID: 17886093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging refinements in renal cell carcinoma.
    Howard GE; Wood CG
    Curr Opin Urol; 2006 Sep; 16(5):317-20. PubMed ID: 16905974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current insights in renal cell cancer pathology.
    Mancini V; Battaglia M; Ditonno P; Palazzo S; Lastilla G; Montironi R; Bettocchi C; Cavalcanti E; Ranieri E; Selvaggi FP
    Urol Oncol; 2008; 26(3):225-38. PubMed ID: 18452811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    Cancer; 2007 Jun; 109(12):2439-44. PubMed ID: 17487856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.
    Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M
    J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, clinical staging, and presentation of renal cell carcinoma.
    Decastro GJ; McKiernan JM
    Urol Clin North Am; 2008 Nov; 35(4):581-92; vi. PubMed ID: 18992612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic renal cell carcinoma: biology and clinical behavior.
    Han KR; Janzen NK; McWhorter VC; Kim HL; Pantuck AJ; Zisman A; Figlin RA; Dorey FJ; Said JW; Belldegrun AS
    Urol Oncol; 2004; 22(5):410-4. PubMed ID: 15464922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the staging of renal cell carcinoma.
    Leung AC; Ghavamian R
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):673-80. PubMed ID: 12503213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.